Award

Howard University 5R16GM145483-04

Multifunctional Nanotechnology Platform for Triple Negative Breast Cancer Treatment

Recipient

Howard University, Washington, DC, United States

Award Amount

$154,500.00

Ceiling

$154,500.00

Awarded

July 23, 2025

Identifier

5R16GM145483-04

Award for developing a nanotechnology platform to treat triple-negative breast cancer using biodegradable nanoparticles and combination drug therapy.

Description

The project involves developing biodegradable polymeric nanoparticles for targeted breast cancer therapy. The project aims to improve outcomes for triple-negative breast cancer patients using nanotechnology, targeted delivery, and combination drug therapy.

View original record